Cytotoxicity and apoptotic-inducing effect of 1-(1-tosyl-1H-indol-3yl)propan-1-one against lung cancer cells

Author:

Bonifacio Joao Henrique Oliveira1,Franca Mariana Nobre Farias1,Melo Marcos Vinicius Barbosa2,Santos Jileno Ferreira2,Oliveira Cristiane Almeida Santos2,Amaral Ricardo Guimaraes3,Cavalcanti Sócrates Cabral de Holanda4,Correa Cristiane Bani1

Affiliation:

1. Health Science Graduate Program, Federal University of Sergipe

2. Physiological Sciences Graduate Program, Federal University of Sergipe

3. Medicine Department, Federal University of Sergipe

4. Pharmacy Department, Federal University of Sergipe

Abstract

Abstract

Background Lung cancer is the most prevalent and deadly cancer in the world. In the search for new antineoplastic drugs, research into derivatives of natural products revealed the constant evolution of science to provide treatments with fewer adverse effects. Indole is a natural compound found in plants and microorganisms with proven antitumor activity. Modifications to its structure can potentiate its cytotoxic effect on tumor cells. Thus, the aim of this study was to evaluate the cytotoxic potential of the synthetic indole derivative 1-(1-tosyl-1H-indol-3-yl)propan-1-one in tumor cell lines. Methods Sulforhodamine B (SRB) was used to evaluate the cytotoxic effect of compound 1-(1-tosyl-1H-indol-3-yl)propan-1-one against lung cancer (A549), breast cancer (MCF7) and prostate cancer (PC-3) cell lines. Furthermore, the hemolysis assay was carried out on human erythrocytes. The clonogenic and wound healing assays were used to analyze the reduction in colony formation and the migratory capacity of the A549 cell line, respectively. DAPI and Phalloidin/FITC were used to observe morphological changes. Death by apoptosis and necrosis were assessed by flow cytometer. Results The highest inhibitory effect was observed in the A549 cell line, with an IC50 of 2.6 µM. The A549 cell line was further selected for additional biological tests, considering the IC50 and the epidemiological relevance of this cancer. No hemolytic activity was observed in human erythrocytes after exposure to 1-(1-tosyl-1H-indol-3-yl)propan-1-one. In the colony formation test, clone inhibition was observed in the A549 cell line at a concentration of 5.2 µM. In the migration analysis, we observed that the compound inhibited wound closure in the A549 cells at the highest concentrations after 48 h of treatment. In addition, morphological changes characteristic of apoptosis, such as cytoplasmic reduction and changes in the disposition of actin filaments, were observed in the A549 cell line by staining with DAPI and phalloidin/FITC dyes. These results corroborate the flow cytometry results, which showed that the treatment induced apoptosis in the A549 cells. Conclusions Our results showed that the compound 1-(1-tosyl-1H-indol-3-yl)propan-1-one inhibited cell growth, migration and colony formation and promote cell death via apoptosis in A549 cell line.

Publisher

Springer Science and Business Media LLC

Reference50 articles.

1. AHMAD A et al. Pentafluorophenyl Substitution of Natural Di(indol-3‐yl) methane Strongly Enhances Growth Inhibition and Apoptosis Induction in Various Cancer Cell Lines. Chemistry & Biodiversity, v. 16, n. 4, 19 abr. 2019.

2. ANDRADE AK, DE S et al. Anti-migratory and cytotoxic effect of indole derivative in C6 glioma cells. Toxicology in Vitro, v. 96, p. 105786, abr. 2024.

3. Natural Products/Bioactive Compounds as a Source of Anticancer Drugs. Cancers, v. 14, n. 24;ASMA ST,2022a

4. ASMA ST et al. Natural Products/Bioactive Compounds as a Source of Anticancer Drugs. Cancers, v. 14, n. 24, 15 dez. 2022b.

5. Radioterapia no câncer de pulmão. Jornal de Pneumologia, v. 28, n. 6;CARVALHO HDA,2002

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3